Metabolic Disorders Are Associated With Drug-Induced Liver Injury During Antituberculosis Treatment: A Multicenter Prospective Observational Cohort Study in Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lim, Jihye | - |
dc.contributor.author | Kim, Ju Sang | - |
dc.contributor.author | Kim, Hyung Woo | - |
dc.contributor.author | Kim, Yong Hyun | - |
dc.contributor.author | Jung, Sung Soo | - |
dc.contributor.author | Kim, Jin Woo | - |
dc.contributor.author | Oh, Jee Youn | - |
dc.contributor.author | Lee, Heayon | - |
dc.contributor.author | Kim, Sung Kyoung | - |
dc.contributor.author | Kim, Sun-Hyung | - |
dc.contributor.author | Lyu, Jiwon | - |
dc.contributor.author | Ko, Yousang | - |
dc.contributor.author | Kwon, Sun Jung | - |
dc.contributor.author | Jeong, Yun-Jeong | - |
dc.contributor.author | Kim, Do Jin | - |
dc.contributor.author | Koo, Hyeon-Kyoung | - |
dc.contributor.author | Jegal, Yangjin | - |
dc.contributor.author | Kyung, Sun Young | - |
dc.contributor.author | An, Tai Joon | - |
dc.contributor.author | Min, Jinsoo | - |
dc.date.accessioned | 2024-02-28T13:30:19Z | - |
dc.date.available | 2024-02-28T13:30:19Z | - |
dc.date.issued | 2023-08 | - |
dc.identifier.issn | 2328-8957 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/90505 | - |
dc.description.abstract | Background. Drug-induced liver injury (DILI) may lead to the discontinuation of antituberculosis (anti-TB) treatment (ATT). Some studies have suggested that metabolic disorders increase the risk of DILI during ATT. This study aimed to identify risk factors for DILI, particularly metabolic disorders, during ATT. Methods. A multicenter prospective observational cohort study to evaluate adverse events during ATT was conducted in Korea from 2019 to 2021. Drug-susceptible patients with TB who had been treated with standard ATT for 6 months were included. The patients were divided into 2 groups depending on the presence of 1 or more metabolic conditions, such as insulin resistance, hypertension, obesity, and dyslipidemia. We monitored ATT-related adverse events, including DILI, and treatment outcomes. The incidence of DILI was compared between individuals with and without metabolic disorders, and related factors were evaluated. Results. Of 684 patients, 52 (7.6%) experienced DILI, and 92.9% of them had metabolic disorders. In the multivariable analyses, underlying metabolic disorders (adjusted hazard ratio [aHR], 2.85; 95% CI, 1.01-8.07) and serum albumin <3.5g/dL (aHR, 2.26; 95% CI, 1.29-3.96) were risk factors for DILI during ATT. In the 1-month landmark analyses, metabolic disorders were linked to an elevated risk of DILI, especially significant alanine aminotransferase elevation. The treatment outcome was not affected by the presence of metabolic disorders. Conclusions. Patients with metabolic disorders have an increased risk of ATT-induced liver injury compared with controls. The presence of metabolic disorders and hypoalbuminemia adversely affects the liver in patients with ATT. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | OXFORD UNIV PRESS INC | - |
dc.title | Metabolic Disorders Are Associated With Drug-Induced Liver Injury During Antituberculosis Treatment: A Multicenter Prospective Observational Cohort Study in Korea | - |
dc.type | Article | - |
dc.identifier.wosid | 001154999800005 | - |
dc.identifier.doi | 10.1093/ofid/ofad422 | - |
dc.identifier.bibliographicCitation | OPEN FORUM INFECTIOUS DISEASES, v.10, no.8 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85171995545 | - |
dc.citation.title | OPEN FORUM INFECTIOUS DISEASES | - |
dc.citation.volume | 10 | - |
dc.citation.number | 8 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | antitubercular agents | - |
dc.subject.keywordAuthor | chemical and drug-induced liver injury | - |
dc.subject.keywordAuthor | metabolic syndrome | - |
dc.subject.keywordAuthor | risk factors | - |
dc.subject.keywordAuthor | tuberculosis | - |
dc.subject.keywordPlus | PHENOTYPE | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalResearchArea | Microbiology | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Microbiology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.